Mustang Bio
MBIO
48 hedge funds and large institutions have $3.6M invested in Mustang Bio in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 13 reducing their positions, and 16 closing their positions.
0% less ownership
Funds ownership: 0.01% → 0.01% (-0%)
20% less funds holding
Funds holding: 60 → 48 (-12)
38% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 13
67% less capital invested
Capital invested by funds: $10.8M → $3.6M (-$7.24M)
69% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 16
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$31.6K |
| 2 |
Millennium Management
New York
|
+$20.5K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$12.3K |
| 4 |
NW
NewEdge Wealth
Pittsburgh,
Pennsylvania
|
+$8.2K |
| 5 |
US Bancorp
Minneapolis,
Minnesota
|
+$8.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$168K |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$158K |
| 3 |
HighTower Advisors
Chicago,
Illinois
|
-$115K |
| 4 |
BlackRock
New York
|
-$110K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$84K |
MBIO Hedge Fund Activity: Q1 2023 in Review
48 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Mustang Bio (MBIO) for Q1 2023, worth a combined $3.6M — down 67% from $10.8M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of MBIO and 5 opened new positions — a net loss of 11 holders — while 13 trimmed existing stakes and 8 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $31.6K. The largest seller was Renaissance Technologies, cutting an estimated $168K.
- 48 institutional investors held Mustang Bio (MBIO) as of Q1 2023, down from 60 in Q4 2022.
- Funds reported $3.6M of Mustang Bio stock for Q1 2023, down 67% quarter-over-quarter.
- 5 funds opened new Mustang Bio positions in Q1 2023 and 16 closed out, a net change of -11 holders.
- The largest Mustang Bio buyer in Q1 2023 was Citadel Advisors, an estimated $31.6K added.
- The largest Mustang Bio seller in Q1 2023 was Renaissance Technologies, an estimated $168K sold.
Based on aggregated 13F filings for Q1 2023.